摘要
目的:研究促凋亡基因bax在骨巨细胞瘤中的表达及其与Jafe分级和预后的关系。方法:采用兔抗人Bax多克隆抗体及免疫组织化学SABC法。结果:73例骨巨细胞瘤中,Bax阳性47例(644%);其中Jafe病理分级中Ⅰ级27例中,阳性22例(815%),Ⅱ级38例中阳性23例(605%),Ⅲ级8例中,2例阳性(250%),P<005。在不同预后分组中Bax阳性率间无显著差异(P>005)。结论:促凋亡基因在骨巨细胞瘤中不同程度的表达可能参与骨巨细胞瘤凋亡的调节,并与肿瘤分化程度有关。单一Bax表达不能反应预后。
Objective:To study the expression of proapoptosis gene Bax in giant cell tumor of bone,and its relationship with Jaffe pathologic grading and prognostic significance.Method:Streptavidin Biotin peroxidase Complex(SABC) methods,polyclonal antibody against Bax protein on archival material were employed.Results:Bax was positive in 47 cases of all 73 specimen of giant cell tumor.According to Jaffe pathologic grading,81 2%(22/27) of grade Ⅰ specimen were positive;60 5%(23/38) of grape Ⅱ positive;25 0%(2/8) of grade Ⅲ positive.There was significant difference between expression of Bax in grade Ⅰ、Ⅱ、Ⅲ group ( P <0 05).While there was no obvious difference between expression of in cure、recurrence and metastases group.( P >0 05).Conclusion:The result suggests that proapoptosis gene Bax are differently expressed in most of giant cell tumor of bone and Bax may take part in the modulation of apoptosis and is associated with the differentiation of giant cell tumor of bone.Bax is not associated with prognosis.
出处
《中国矫形外科杂志》
CAS
CSCD
1999年第5期358-359,共2页
Orthopedic Journal of China